Teva says Israel probing same issues as US bribery case

By REUTERS
February 7, 2017 19:43

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Teva Pharmaceutical Industries said on Tuesday that Israeli authorities were investigating the same issues as an earlier US bribery settlement.

"The company can confirm that, to the best of its knowledge, an investigation is being conducted in Israel regarding the same issues which led to a settlement with American justice authorities," a spokesman said in a statement.

"The settlement referred to events that occurred between 2007-2012 and none of the people involved in the improper payments is currently employed at Teva," the statement said.

Teva in December agreed to pay more than $519 million to settle US criminal and civil allegations that the company bribed overseas officials to gain business for its medications.

Related Content

Breaking news
August 20, 2018
King of Morocco appoints new minister for economy and finance

By REUTERS